PERSPECTA

News from every angle

← Back to headlines

Sweden Denies Alzheimer's Drug Leqembi to Patients

Swedish authorities have decided not to make a new Alzheimer's drug, Leqembi, available to patients in Sweden. The decision is based on the assessment that the drug currently lacks proven benefit for patients.

PostShare

Sources

Showing 0 of 2 sources

No articles available in your preferred languages.

2 articles available in other languages below.

aftonbladetSwedish17d ago

Inget alzheimerläkemedel till svenska patienter

Sjukvården avråds från att använda den svenskutvecklade Alzheimermedicinen Lecanemab, rapporterar Ekot.

Read full article →
svenska-dagbladetSwedish17d ago

Inget alzheimerläkemedel till svenska patienter

Read full article →

Coverage Timeline

First report: aftonbladet · 17 Apr, 09:41Full coverage: 2 · 0mWindow: 0m
Left-leaningCenterRight-leaning
aftonbladet17 Apr, 09:41First to report

Inget alzheimerläkemedel till svenska patienter

svenska-dagbladet17 Apr, 09:41Latest update

Inget alzheimerläkemedel till svenska patienter

Related Stories

Suspected drunk driver injures pedestrians at Lag Ba'Omer celebration in Beersheba

just now

Philippines Faces, Experiences 'Danger Level' Heat Index

just now

Philippines Forecasts Danger-Level Heat Indices in 15 Areas

just now

Philippines Records 'Danger' Level Heat Indices in 20 Areas

2m ago